Related Experiment Video
Updated: Apr 5, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Modelling the Future: System Dynamics in the Cutaneous Malignant Melanoma Care Pathway
Magdalena Claeson1, Stefan Hallberg, Paul Holmström
1Department of Dermatology and Venereology, Sahlgrenska Academy, SE-413 45 Gothenburg, Sweden. magdalena.claeson@vgregion.se.
Implementing improved secondary prevention strategies can significantly reduce future cutaneous malignant melanoma cases. This approach, combining reduced patient and doctor delays, offers a powerful tool for public health planning.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Global incidence rates of cutaneous malignant melanoma are rising.
- Accurate future case estimations are crucial for healthcare planning.
- Melanoma prevention strategies require evaluation for maximum impact.
Purpose of the Study:
- To utilize system dynamics modeling for evaluating long-term effects of melanoma incidence, population growth, and preventive interventions.
- To forecast melanoma case numbers and assess the impact of different intervention scenarios.
Main Methods:
- System dynamics modeling was employed.
- Historical invasive melanoma data from Western Sweden (1990-2006) were used.
- Computer simulations projected cases for 2014-2023 under five scenarios.
Main Results:
- 'Improved overall secondary prevention' (reduced patient and doctor delays) showed significant impact.
- This scenario led to a 42% decrease in melanomas > 4 mm after 10 years.
- A 10% increase in melanomas ≤ 1 mm was observed, indicating earlier detection.
Conclusions:
- System dynamics modeling is effective for assessing public health interventions.
- Reducing patient and doctor delays is a key strategy for mitigating melanoma burden.
- Policymakers can use these insights to prioritize effective melanoma prevention efforts.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
Cancer Survival Analysis
Pharmacodynamic Models: Overview

